Stocks Health care DTIL
NASDAQ · Health carePrecision Biosciences Inc (DTIL)
Precision Biosciences Inc brought in $45.1M of revenue over the twelve months to June 30, 2026, up 3,473.0% from a year earlier. It posted a net loss of $52.7M. In fiscal 2025 capital spending exceeded operating cash flow by $65.9M. At June 30, 2026 it held $86.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
What Precision Biosciences Inc does
Precision Biosciences Inc is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker DTIL.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $34.3M | -$45.7M | -$3.56 | -$65.9M |
| 2024 | $68.7M | $7.2M | $1.04 | -$58.7M |
| 2023 | $48.7M | -$61.3M | -$15.96 | -$86.1M |
| 2022 | $25.1M | -$111.6M | -$38.10 | -$49.1M |
| 2021 | $115.5M | -$30.6M | -$15.60 | -$15.9M |
| 2020 | $24.3M | -$109M | -$62.70 | -$92.4M |
Latest SEC filings
What Precision Biosciences Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 24, 2026Passive stake changed SCHEDULE 13G/A
- August 24, 2026
- August 7, 2026
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026
- August 6, 2026
- July 29, 2026Passive stake changed SCHEDULE 13G/A
- July 27, 2026
- July 20, 2026Passive stake (5% or more) SCHEDULE 13G
- July 1, 2026
- June 16, 2026
Questions about DTIL
What does Precision Biosciences Inc do?
Precision Biosciences Inc is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker DTIL.
Is Precision Biosciences Inc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $52.7M on revenue of $45.1M.
How much revenue does Precision Biosciences Inc make?
Over the twelve months to June 30, 2026 Precision Biosciences Inc reported revenue of $45.1M. That is 3,473.0% more than a year earlier.
When did Precision Biosciences Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake changed from August 24, 2026.
Similar companies
Follow DTIL
Get an email when Precision Biosciences Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow DTIL: get an email when it filesWhere the numbers come from
Financial figures are the values Precision Biosciences Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.